Literature DB >> 10319895

Congenital hypomyelination due to myelin protein zero Q215X mutation.

P Mandich1, G L Mancardi, A Varese, S Soriani, E Di Maria, E Bellone, M Bado, L Gross, A J Windebank, F Ajmar, A Schenone.   

Abstract

Congenital hypomyelination (CH) is a hereditary demyelinating peripheral neuropathy characterized by early infancy onset, distal muscle weakness, hypotonia, areflexia, and severe slowing of nerve conduction velocities. In the present report, the clinical, morphological, and immunohistochemical features of a CH case and the identification of a mutation in the gene (MPZ) for protein zero (P0) associated with this phenotype are described. This "de novo" mutation in a patient presenting with clinical features quite distinct from those of the more frequent Charcot-Marie-Tooth type 1B disease (CMT1B) or Dejerine-Sottas syndrome (DSS) confirms that CH is allelic with other disorders characterized by a less severe phenotype and a different clinical and neuropathological profile.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10319895     DOI: 10.1002/1531-8249(199905)45:5<676::aid-ana21>3.0.co;2-k

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Authors:  Sophie Belin; Francesca Ornaghi; Ghjuvan'Ghjacumu Shackleford; Jie Wang; Cristina Scapin; Camila Lopez-Anido; Nicholas Silvestri; Neil Robertson; Courtney Williamson; Akihiro Ishii; Carla Taveggia; John Svaren; Rashmi Bansal; Markus H Schwab; Klaus Nave; Pietro Fratta; Maurizio D'Antonio; Yannick Poitelon; M Laura Feltri; Lawrence Wrabetz
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

2.  Four novel mutations of the myelin protein zero gene presenting as a mild and late-onset polyneuropathy.

Authors:  Ilka Kleffner; Anja Schirmacher; Burkhard Gess; Matthias Boentert; Peter Young
Journal:  J Neurol       Date:  2010-06-18       Impact factor: 4.849

Review 3.  Mechanisms and Treatments in Demyelinating CMT.

Authors:  Vera Fridman; Mario A Saporta
Journal:  Neurotherapeutics       Date:  2021-11-08       Impact factor: 6.088

Review 4.  Dejerine-Sottas syndrome grown to maturity: overview of genetic and morphological heterogeneity and follow-up of 25 patients.

Authors:  Anneke Gabreëls-Festen
Journal:  J Anat       Date:  2002-04       Impact factor: 2.610

Review 5.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

6.  A nonsense mutation in myelin protein zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function.

Authors:  Pietro Fratta; Francesca Ornaghi; Gabriele Dati; Desirée Zambroni; Paola Saveri; Sophie Belin; Patrizia D'Adamo; Michael Shy; Angelo Quattrini; M Laura Feltri; Lawrence Wrabetz
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

7.  Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.

Authors:  Oranee Sanmaneechai; Shawna Feely; Steven S Scherer; David N Herrmann; Joshua Burns; Francesco Muntoni; Jun Li; Carly E Siskind; John W Day; Matilde Laura; Charlotte J Sumner; Thomas E Lloyd; Sindhu Ramchandren; Rosemary R Shy; Tiffany Grider; Chelsea Bacon; Richard S Finkel; Sabrina W Yum; Isabella Moroni; Giuseppe Piscosquito; Davide Pareyson; Mary M Reilly; Michael E Shy
Journal:  Brain       Date:  2015-08-25       Impact factor: 13.501

8.  Spinal muscular atrophy with respiratory distress type 1 (SMARD1) Report of a Spanish case with extended clinicopathological follow-up.

Authors:  Beatriz San Millan; Jose M Fernandez; Carmen Navarro; Alfredo Reparaz; Susana Teijeira
Journal:  Clin Neuropathol       Date:  2016 Mar-Apr       Impact factor: 1.368

9.  Aminosalicylic acid reduces ER stress and Schwann cell death induced by MPZ mutations.

Authors:  Eun Hyuk Chang; Won Min Mo; Hyun Myung Doo; Ji-Su Lee; Hwan Tae Park; Byung-Ok Choi; Young Bin Hong
Journal:  Int J Mol Med       Date:  2019-05-02       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.